Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Frenova Renal Research has added an additional location to its roster of managed clinical research sites.
read more
Sterling Pharma Solutions has appointed Dr. Mathew Minardi as its President US Operations.
read more
Aldevron announced its new fermentation capacity of 1,000 liters and plans to increase the Company’s manufacturing footprint in Madison, WI.
read more
GSK has announced $100 million of new investment in its manufacturing site in Montana to expand production capacity of key components of the adjuvant system used in several of GSK's vaccines.
read more
Sharp has invested $21 million in expanding capacity and capabilities at its Allentown and Conshohocken Pennsylvania facilities.
read more
Canopy Biosciences has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry.
read more
Precigen announced the official opening of its new manufacturing facility.
read more
Catalent announced it is investing up to $40 million at its manufacturing facility in Winchester, Kentucky.
read more
Eli Lilly and Company has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, as well as a manufacturing facility in Suzhou, China to Eddingpharm.
read more
Catalent announced it began Phase 2 clinical trials of MGB Biopharma.
read more
Omnicell announced The University of Tennessee Medical Center will expand its Omnicell® automated medication management platform.
read more
StemExpress now includes distribution partnerships with ATCG Limited, Kim & Friends, BIOTOOLS, Axil Scientific Pte and Custom Science.
read more
Wednesday, April 24, 2019
Arrowhead has begun dosing in a new triple combination cohort that includes JNJ-3989 and additional undisclosed agents selected by Janssen in its ongoing Phase 1/2 study in patients with chronic HBV.
read more
Wednesday, April 24, 2019
Macrogen announced it has signed a supply contract with Exosome Plus to become the exclusive buyer of the exosome isolation kits developed by Exosome Plus.
read more
Wednesday, April 24, 2019
BurstIQ and the ITA announced the formation of a Strategic Partnership focused on promoting blockchain, healthcare best practices, and strategic domestic and international initiatives.
read more